141 related articles for article (PubMed ID: 21783284)
1. Synthesis and biological evaluation of some novel cyclic-imides as hypoglycaemic, anti-hyperlipidemic agents.
Abdel-Aziz AA; El-Azab AS; Attia SM; Al-Obaid AM; Al-Omar MA; El-Subbagh HI
Eur J Med Chem; 2011 Sep; 46(9):4324-9. PubMed ID: 21783284
[TBL] [Abstract][Full Text] [Related]
2. Antihyperglycemic and antihyperlipidemic effects of newly synthesized glibenclamide analogues on streptozotocin-diabetic rats.
Ahmadi A; Khalili M; Farsadrooh M; Ghiasi M; Nahri-Niknafs B
Drug Res (Stuttg); 2013 Dec; 63(12):614-9. PubMed ID: 23828271
[TBL] [Abstract][Full Text] [Related]
3. Microwave-assisted synthesis, hypolipidemic and hypoglycemic activity of some novel 2-(4-(2-Amino-6-(4-substituted phenyl)-pyrimidin-4-yl)-phenoxy)-2-methyl propanoic acid derivatives.
Mokale SN; Elgire RD; Sakle NS; Shinde DB
Arch Pharm (Weinheim); 2012 Jan; 345(1):22-7. PubMed ID: 22076967
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives.
Sashidhara KV; Kumar A; Kumar M; Srivastava A; Puri A
Bioorg Med Chem Lett; 2010 Nov; 20(22):6504-7. PubMed ID: 20932744
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, hypoglycaemic, hypolipidemic and PPARγ agonist activities of 5-(2-Alkyl/aryl-6-Arylimidazo[2,1-b][1,3,4]thiadiazol-5-yl)methylene-1,3-thiazolidinediones.
Khazi MI; Belavagi NS; Kim KR; Gong YD; Khazi IA
Chem Biol Drug Des; 2013 Aug; 82(2):147-55. PubMed ID: 23581650
[TBL] [Abstract][Full Text] [Related]
6. Flavone-based novel antidiabetic and antidyslipidemic agents.
Verma AK; Singh H; Satyanarayana M; Srivastava SP; Tiwari P; Singh AB; Dwivedi AK; Singh SK; Srivastava M; Nath C; Raghubir R; Srivastava AK; Pratap R
J Med Chem; 2012 May; 55(10):4551-67. PubMed ID: 22524508
[TBL] [Abstract][Full Text] [Related]
7. Hypoglycemic and hypolipidemic effects of Coriandrum sativum L. in Meriones shawi rats.
Aissaoui A; Zizi S; Israili ZH; Lyoussi B
J Ethnopharmacol; 2011 Sep; 137(1):652-61. PubMed ID: 21718774
[TBL] [Abstract][Full Text] [Related]
8. Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione.
Lee HW; Kim BY; Ahn JB; Kang SK; Lee JH; Shin JS; Ahn SK; Lee SJ; Yoon SS
Eur J Med Chem; 2005 Sep; 40(9):862-74. PubMed ID: 15908051
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and in vivo screening of some novel quinazoline analogs as anti-hyperlipidemic and hypoglycemic agents.
Mokale SN; Palkar AD; Dube PN; Sakle NS; Miniyar PB
Bioorg Med Chem Lett; 2016 Jan; 26(2):272-276. PubMed ID: 26707395
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives.
Rathish IG; Javed K; Bano S; Ahmad S; Alam MS; Pillai KK
Eur J Med Chem; 2009 Jun; 44(6):2673-8. PubMed ID: 19171410
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of some novel analogues of 4-(1-Pyrrolidinyl) Piperidine and their effect on plasma glucose level.
Mushtaq N; Saify ZS; Akhtar S; Arif M; Haider S; Saba N
Pak J Pharm Sci; 2010 Apr; 23(2):220-3. PubMed ID: 20363703
[TBL] [Abstract][Full Text] [Related]
12. Discovery of tetrahydrocarbazoles with potent hypoglycemic and hypolipemic activities.
Zhang JQ; Li SM; Ma X; Zhong G; Chen R; Li XS; Zhu GF; Zhou B; Guo B; Wu HS; Tang L
Eur J Med Chem; 2018 Apr; 150():102-112. PubMed ID: 29525431
[TBL] [Abstract][Full Text] [Related]
13. Identification of trans-tiliroside as active principle with anti-hyperglycemic, anti-hyperlipidemic and antioxidant effects from Potentilla chinesis.
Qiao W; Zhao C; Qin N; Zhai HY; Duan HQ
J Ethnopharmacol; 2011 May; 135(2):515-21. PubMed ID: 21463674
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis and biological evaluation of tetrahydrocoptisine quaternary ammonium compounds].
Wang DM; Wei JZ; Fan BY; Liu Q; Zhu HB; Shen ZF; Wu S
Yao Xue Xue Bao; 2012 Dec; 47(12):1640-5. PubMed ID: 23460970
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and investigating hypoglycemic and hypolipidemic activities of some glibenclamide analogues in rats.
Ahmadi A; Khalili M; Khatami K; Farsadrooh M; Nahri-Niknafs B
Mini Rev Med Chem; 2014 Feb; 14(2):208-13. PubMed ID: 24387708
[TBL] [Abstract][Full Text] [Related]
16. Novel euglycemic and hypolipidemic agents: Part-2. Antioxidant moiety as structural motif.
Reddy KA; Lohray BB; Bhushan V; Reddy AS; Kishore PH; Rao VV; Saibaba V; Bajji AC; Rajesh BM; Reddy KV; Chakrabarti R; Rajagopalan R
Bioorg Med Chem Lett; 1998 May; 8(9):999-1002. PubMed ID: 9871696
[TBL] [Abstract][Full Text] [Related]
17. Hypolipidemic activity of phthalimide derivatives V: Reduced and hydrolytic products of simple cyclic imides.
Chapman JM; Wyrick SD; Josée Voorstad P; Maguire JH; Cocolas GH; Hall IH
J Pharm Sci; 1984 Oct; 73(10):1482-4. PubMed ID: 6502502
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone as potential antihyperglycemic and antidyslipidemic agents.
Raza S; Srivastava SP; Srivastava DS; Srivastava AK; Haq W; Katti SB
Eur J Med Chem; 2013 May; 63():611-20. PubMed ID: 23567949
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and hypoglycemic activity of some new theophylline derivatives.
Alafeefy AM; Alqasoumi SI; Abdel Hamid SG; El-Tahir KE; Mohamed M; Zain ME; Awaad AS
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):443-8. PubMed ID: 23701264
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel imidazoline derivatives with potent antihyperglycemic activity in a rat model of type 2 diabetes.
Crane L; Anastassiadou M; El Hage S; Stigliani JL; Baziard-Mouysset G; Payard M; Leger JM; Bizot-Espiard JG; Ktorza A; Caignard DH; Renard P
Bioorg Med Chem; 2006 Nov; 14(22):7419-33. PubMed ID: 16889967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
